ANTI-INFLIXIMAB (IFX) ANTIBODIES - ANVISA Registration 80134860239

Access comprehensive regulatory information for ANTI-INFLIXIMAB (IFX) ANTIBODIES in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80134860239 and manufactured by PROGENIKA BIOPHARMA S.L.. The registration is held by GRIFOLS BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including BODITECH MED INC., BIOSYNEX SA, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.